Trial ID or NCT#

NCT02312882

Status

NOT RECRUITING

Purpose

The purpose of this study is to investigate the ability of tofacitinib citrate, a Janus kinase inhibitor, to generate hair regrowth in patients with moderate to severe alopecia areata and its variants.

Official Title

Tofacitinib for the Treatment of Alopecia Areata and Its Variants

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Justin M Ko, MD, MBA, FAAD
Dermatologist, Melanoma specialist, Psoriasis specialist, Cutaneous oncology specialist
Clinical Associate Professor, Dermatology

Contact us to find out if this trial is right for you.

CONTACT

Michelle Kim